# Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

> **NCT01854684** · PHASE1 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 8 (actual)

## Conditions studied

- Recurrent Non-Small Cell Lung Carcinoma
- Stage IIA Non-Small Cell Lung Carcinoma
- Stage IIB Non-Small Cell Lung Carcinoma
- Stage IIIA Non-Small Cell Lung Cancer
- Stage IIIB Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Temoporfin
- **PROCEDURE:** Therapeutic Conventional Surgery
- **DRUG:** Photodynamic Therapy
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Pharmacological Study

## Key facts

- **NCT ID:** NCT01854684
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-21
- **Primary completion:** 2018-09-04
- **Final completion:** 2018-09-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01854684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01854684, "Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01854684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*